CD4 and diffuse large B-cell lymphoma: Among the TIL, a hi PD-1 and FoxP3+ cell populations have been described in DLBCL microenvironment and the number of PD-1hi and FoxP3+ cells, as well as total CD4+ T-cells are associated with improved clinical outcome [80].